IGF1R and Ewing sarcoma: For the purpose of this discussion, we will focus on two proteins which have recently generated a great deal of interest as potential therapeutic targets in ES; the receptor tyrosine kinase Insulin Growth Factor Receptor 1 (IGF-1R) and Poly (ADP-ribose) polymerase 1 (PARP1).